ARTICLE | Clinical News
PXS4728A: Phase I started
February 2, 2015 8:00 AM UTC
Pharmaxis began the double-blind, placebo-controlled, Australian Phase I PXS-4728A-101 trial to evaluate single and multiple ascending doses of oral PXS4728A in about 72 healthy male volunteers ages 1...